to evaluate 90y-labeled np-2 as a therapeutic agent , varied doses ( 10-100 microci ) were administered as a single i.v . injection into groups of nude mice bearing s.c. implants ( 0.3-0.4 g ) of a cea-producing human colonic cancer xenograft , gw-39 .
C1706141
np
C0086418
human